Inclusion Criteria:

- Patients must be 14-42 year old females with a cancer diagnosis.

- Clearance letter from treating oncologist.

- Approval by program oncologist or her designee.

- Informed consent has to be signed after consultation with the program physician.
Minors require consent of a parent or a legal guardian and assent from the
participant.

- Life expectancy (predicted by their malignancy) of 5 or more years.

- Cancer diagnosis should have an expected cure rate of 50% or more, based upon
clinico-pathologic features.

Exclusion Criteria:

- Patients whose oncologist and the program oncologist concur that immediate oncologic
care should be rendered, not allowing sufficient time for a course of gonadotropin
therapy and egg retrieval.

- FSH level >20 MIU/ml, indicating abnormal ovarian function.

- Patients with stage IV cancers (*age appropriate women with stage IV advanced
Hodgkin's Lymphoma will be considered, as there is a significant long term survival
rate with this advanced disease).

- Patients with incurable cancer diagnoses.

- Patients who are unable or unwilling to sign the informed consent.

- Women cannot have an embryo transfer beyond age 50.